• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞色素 P450 家族 1 抑制剂及其结构-活性关系。

Cytochrome P450 family 1 inhibitors and structure-activity relationships.

机构信息

Department of Chemistry, Xavier University of Louisiana, New Orleans, LA 70125, USA.

出版信息

Molecules. 2013 Nov 25;18(12):14470-95. doi: 10.3390/molecules181214470.

DOI:10.3390/molecules181214470
PMID:24287985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4216474/
Abstract

With the widespread use of O-alkoxyresorufin dealkylation assays since the 1990s, thousands of inhibitors of cytochrome P450 family 1 enzymes (P450s 1A1, 1A2, and 1B1) have been identified and studied. Generally, planar polycyclic molecules such as polycyclic aromatic hydrocarbons, stilbenoids, and flavonoids are considered to potentially be effective inhibitors of these enzymes, however, the details of the structure-activity relationships and selectivity of these inhibitors are still ambiguous. In this review, we thoroughly discuss the selectivity of many representative P450 family 1 inhibitors reported in the past 20 years through a meta-analysis.

摘要

自 20 世纪 90 年代以来,O-烷氧基resorufin 脱烷基化测定法得到广泛应用,数千种细胞色素 P450 家族 1 酶(P450s 1A1、1A2 和 1B1)的抑制剂已被鉴定和研究。通常,平面多环分子,如多环芳烃、芪类和类黄酮,被认为是这些酶的潜在有效抑制剂,然而,这些抑制剂的结构-活性关系和选择性的详细信息仍然不清楚。在这篇综述中,我们通过荟萃分析彻底讨论了过去 20 年报道的许多代表性 P450 家族 1 抑制剂的选择性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/a4f6e96cdbab/molecules-18-14470-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/39eb97bc1a68/molecules-18-14470-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/8547551b6a8d/molecules-18-14470-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/02b24f369e51/molecules-18-14470-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/70ae68e02ffa/molecules-18-14470-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/20afd403968b/molecules-18-14470-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/64433d65823b/molecules-18-14470-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/741c0e1a8fee/molecules-18-14470-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/621cb8e6a526/molecules-18-14470-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/b920d4053d0d/molecules-18-14470-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/2379a573792d/molecules-18-14470-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/a4f6e96cdbab/molecules-18-14470-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/39eb97bc1a68/molecules-18-14470-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/8547551b6a8d/molecules-18-14470-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/02b24f369e51/molecules-18-14470-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/70ae68e02ffa/molecules-18-14470-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/20afd403968b/molecules-18-14470-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/64433d65823b/molecules-18-14470-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/741c0e1a8fee/molecules-18-14470-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/621cb8e6a526/molecules-18-14470-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/b920d4053d0d/molecules-18-14470-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/2379a573792d/molecules-18-14470-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a6/6270050/a4f6e96cdbab/molecules-18-14470-g011.jpg

相似文献

1
Cytochrome P450 family 1 inhibitors and structure-activity relationships.细胞色素 P450 家族 1 抑制剂及其结构-活性关系。
Molecules. 2013 Nov 25;18(12):14470-95. doi: 10.3390/molecules181214470.
2
Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.多环芳烃对人细胞色素P450 1A1、1A2和1B1介导的致癌物向基因毒性代谢物激活的抑制作用。
Chem Res Toxicol. 2006 Feb;19(2):288-94. doi: 10.1021/tx050291v.
3
Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.33 种黄酮类衍生物对人细胞色素 P4501A1、1A2、1B1、2C9 和 3A4 的抑制作用的结构-功能关系。
Chem Res Toxicol. 2010 Dec 20;23(12):1921-35. doi: 10.1021/tx100286d.
4
Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.多环抑制剂对人细胞色素P450 1A1、1A2和1B1的选择性。
Chem Res Toxicol. 1998 Sep;11(9):1048-56. doi: 10.1021/tx980090+.
5
Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.多环芳烃抑制剂对人细胞色素P450 1A1、1A2和1B1的不同抑制机制。
Chem Res Toxicol. 2007 Mar;20(3):489-96. doi: 10.1021/tx600299p. Epub 2007 Feb 10.
6
7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2.7-乙炔基香豆素:人细胞色素 P450s 1A1 和 1A2 的选择性抑制剂。
Chem Res Toxicol. 2012 May 21;25(5):1047-57. doi: 10.1021/tx300023p. Epub 2012 Apr 10.
7
Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102.基于与CYP102的序列同源性对CYP1家族酶CYP1A1、CYP1A2、CYP1A6和CYP1B1进行分子建模。
Toxicology. 1999 Nov 29;139(1-2):53-79. doi: 10.1016/s0300-483x(99)00098-0.
8
Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.四种化学预防有机硒化合物对人细胞色素 P450 1A1、1A2、1B1、2A6 和 2A13 的光谱修饰和催化抑制作用。
Chem Res Toxicol. 2011 Aug 15;24(8):1327-37. doi: 10.1021/tx200218u. Epub 2011 Jul 20.
9
In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1.标准化人参提取物及单体人参皂苷对人CYP1A1、CYP1A2和CYP1B1催化活性的体外作用。
Drug Metab Dispos. 2002 Apr;30(4):378-84. doi: 10.1124/dmd.30.4.378.
10
Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.芳基乙炔作为基于机制的细胞色素P450依赖性单加氧酶的抑制剂
Chem Res Toxicol. 1997 Jan;10(1):91-102. doi: 10.1021/tx960064g.

引用本文的文献

1
Proanthocyanidins inhibit CYP1B1 through mixed-type kinetics and stable binding in molecular dynamics simulations.原花青素通过混合型动力学抑制CYP1B1,并在分子动力学模拟中具有稳定结合。
Sci Rep. 2025 Aug 29;15(1):31877. doi: 10.1038/s41598-025-12781-2.
2
Phytochemical profiling, antioxidant properties, and anticancer activity of Pourouma cecropiifolia Mart. from the Ecuadorian Amazon.来自厄瓜多尔亚马逊地区的 Pourouma cecropiifolia Mart. 的植物化学分析、抗氧化特性及抗癌活性
NPJ Sci Food. 2025 Aug 14;9(1):175. doi: 10.1038/s41538-025-00503-x.
3
Machine Learning-Based Prediction of the Inhibitory Activity of Chemical Substances Against Rat and Human Cytochrome P450s.

本文引用的文献

1
Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling.小檗碱、黄连碱和吴茱萸碱对 CYP1 的抑制作用:选择性、动力学特征和分子模拟。
Toxicol Appl Pharmacol. 2013 Nov 1;272(3):671-80. doi: 10.1016/j.taap.2013.07.005. Epub 2013 Jul 22.
2
Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.吡喃并黄酮类化合物:一组小分子探针,用于探索细胞色素 P450 酶 1A1、1A2 和 1B1 的活性位点腔。
J Med Chem. 2013 May 23;56(10):4082-92. doi: 10.1021/jm4003654. Epub 2013 May 2.
3
Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism.
基于机器学习的化学物质对大鼠和人细胞色素 P450s 抑制活性的预测。
Chem Res Toxicol. 2024 Nov 18;37(11):1843-1850. doi: 10.1021/acs.chemrestox.4c00168. Epub 2024 Oct 20.
4
A Systematic Review of the Gene-Lifestyle Interactions on Metabolic Disease-Related Outcomes in Arab Populations.一项关于基因-生活方式相互作用对阿拉伯人群代谢性疾病相关结局影响的系统评价。
Nutrients. 2024 Aug 1;16(15):2519. doi: 10.3390/nu16152519.
5
Enzyme Inhibitors from Gorgonians and Soft Corals.海葵和软珊瑚中的酶抑制剂。
Mar Drugs. 2023 Jan 31;21(2):104. doi: 10.3390/md21020104.
6
Upregulation of CYP1B1 by hypoxia is mediated by ERα activation in breast cancer cells.缺氧介导的乳腺癌细胞中CYP1B1上调是由雌激素受体α(ERα)激活所介导的。
Am J Cancer Res. 2022 Jun 15;12(6):2798-2816. eCollection 2022.
7
In Silico Design and SAR Study of Dibenzyl Trisulfide Analogues for Improved CYP1A1 Inhibition.计算机辅助设计及二苄基三硫醚类似物构效关系研究对 CYP1A1 抑制作用的改善。
ChemistryOpen. 2022 May;11(5):e202200016. doi: 10.1002/open.202200016.
8
Cytochrome P450 1B1: role in health and disease and effect of nutrition on its expression.细胞色素P450 1B1:在健康与疾病中的作用以及营养对其表达的影响
RSC Adv. 2019 Jul 4;9(36):21050-21062. doi: 10.1039/c9ra03674a. eCollection 2019 Jul 1.
9
Role of Phytochemicals in Cancer Chemoprevention: Insights.植物化学物质在癌症化学预防中的作用:见解
Antioxidants (Basel). 2021 Sep 14;10(9):1455. doi: 10.3390/antiox10091455.
10
Screening of Human CYP1A2 and CYP3A4 Inhibitors from Seaweed In Silico and In Vitro.海洋藻类药物 CYP1A2 和 CYP3A4 抑制剂的计算机筛选与体外检测
Mar Drugs. 2020 Nov 29;18(12):603. doi: 10.3390/md18120603.
人细胞色素 P450 1A1 结构及其在药物和外源性化合物代谢理解中的应用。
J Biol Chem. 2013 May 3;288(18):12932-43. doi: 10.1074/jbc.M113.452953. Epub 2013 Mar 18.
4
Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2.黄酮炔丙基醚作为细胞色素P450酶1A1和1A2的强效选择性抑制剂的开发。
Drug Metab Lett. 2012;6(4):275-84. doi: 10.2174/1872312811206040007.
5
In vitro inhibitory effect of luotonin A on human CYP1A.芦丁酮 A 对人 CYP1A 的体外抑制作用。
Arch Pharm Res. 2012 Dec;35(12):2199-203. doi: 10.1007/s12272-012-1218-0. Epub 2012 Dec 21.
6
Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1.新型反式白藜芦醇类似物对人重组 CYP1A1、CYP1A2 和 CYP1B1 的抑制选择性的设计、合成与评价。
Bioorg Med Chem. 2012 Sep 1;20(17):5117-26. doi: 10.1016/j.bmc.2012.07.012. Epub 2012 Jul 17.
7
Bergamottin is a competitive inhibitor of CYP1A1 and is antimutagenic in the Ames test.佛手柑素是 CYP1A1 的竞争性抑制剂,在 Ames 试验中具有抗突变性。
Food Chem Toxicol. 2012 Sep;50(9):3094-9. doi: 10.1016/j.fct.2012.05.058. Epub 2012 Jun 13.
8
Contributions of human enzymes in carcinogen metabolism.人类酶在致癌物代谢中的作用。
Chem Res Toxicol. 2012 Jul 16;25(7):1316-83. doi: 10.1021/tx300132k. Epub 2012 May 10.
9
Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.氨基黄酮激活芳香烃受体:肾癌治疗的新分子靶点。
Int J Oncol. 2012 Jul;41(1):125-34. doi: 10.3892/ijo.2012.1427. Epub 2012 Apr 5.
10
7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2.7-乙炔基香豆素:人细胞色素 P450s 1A1 和 1A2 的选择性抑制剂。
Chem Res Toxicol. 2012 May 21;25(5):1047-57. doi: 10.1021/tx300023p. Epub 2012 Apr 10.